Highlights
- The Nifty 50 gained 80.75 points, or 0.34 per cent, to close at 23,962.80 on Thursday, 9 July 2026.
- Sun Pharma rose 2.53 per cent, with SBI Life up 2.43 per cent and Bharti Airtel 2.36 per cent.
- Dr Reddy's, Eicher Motors and Maruti Suzuki ended among the index's biggest losers.
- Nifty Realty surged 3.54 per cent to top the sectoral charts as bargain buying returned.
Indian equities snapped back from their steepest fall of the month, with the Nifty 50 climbing 80.75 points, or 0.34 per cent, to close at 23,962.80 on Thursday, 9 July 2026. The Sensex added 238.22 points to settle at 76,741.82. The rebound was built on bargain buying after Wednesday's Middle East-driven slide of more than 2 per cent, though the benchmark stopped short of reclaiming the 24,000 mark it had touched intraday at 24,134.70.
Movers That Shaped the Session
Sun Pharmaceutical Industries (NSE:SUNPHARMA) led the index with a 2.53 per cent rise to Rs 1,936, followed by SBI Life Insurance (NSE:SBILIFE), up 2.43 per cent, and Bharti Airtel (NSE:BHARTIARTL), up 2.36 per cent. Grasim Industries, Shriram Finance and Max Healthcare also closed firmly higher. On the losing side, Dr Reddy's Laboratories (NSE:DRREDDY) fell nearly 6 per cent after a semaglutide supply setback, while Eicher Motors (NSE:EICHERMOT) and Maruti Suzuki (NSE:MARUTI) slipped amid profit booking in autos.
Why Investors Are Watching
Thursday's recovery tested whether domestic buying could absorb geopolitical shock, and the answer was a qualified yes: domestic institutions purchased equities worth about Rs 2,058 crore against foreign selling of roughly Rs 533 crore. Sector rotation was equally telling. Nifty Realty jumped 3.54 per cent to top the sectoral tables, followed by media and PSU banks, while defensives in healthcare and telecom did the heavy lifting among index heavyweights.
Market Context
The session unfolded against elevated crude prices, with Brent near 79 dollars a barrel after the week's spike, and a rupee trading around 95.5 to the dollar. Broader markets outpaced the benchmark, the midcap gauge rising 1.38 per cent and the smallcap index 1.8 per cent, a divergence that suggested risk appetite persisted beneath the cautious headline move. A constructive stance on Indian equities from a global brokerage added to the improved undertone.
What Market Participants Will Monitor
Friday's session inherits a dense catalyst list: reaction to the first major Q1 FY27 IT results released after Thursday's close, crude oil's next move, and the index's behaviour around 24,000. Technical observers flag 23,926-24,094 as the band whose resolution will determine near-term direction.
Peer Index Perspective
The rebound was regionally distinctive, driven by domestic flows rather than a global risk rally. Within India, the outperformance of midcap and smallcap indices over the Nifty 50 marked a second consecutive session of broader-market leadership, while the Bank Nifty held above 57,000.
Conclusion
One session does not repair a shock, but Thursday showed the dip attracting committed domestic buyers and defensive leadership stabilising the index. Whether the Nifty converts this into a sustained reclaim of 24,000 now rests with earnings and oil.
FAQs
Q: Why is the company in focus today?
A: The Nifty 50 is in focus after rebounding 80.75 points to 23,962.80 on 9 July 2026, recovering part of the previous session's Middle East-driven plunge. Leadership from Sun Pharma, SBI Life and Bharti Airtel defined the move.
Q: What factors are investors monitoring?
A: Investors are watching the index's attempt to reclaim 24,000, reaction to the first big Q1 FY27 results, crude oil prices and daily institutional flows. The 23,926-24,094 technical band frames the near-term range.
Q: Which peer companies are relevant?
A: Index heavyweights drove the session: Sun Pharma, SBI Life and Bharti Airtel led gains while Dr Reddy's, Eicher Motors and Maruti Suzuki lagged. Realty constituents such as Lodha Developers powered the top sectoral index.
Q: Is this article investment advice?
A: No. This article is intended solely for informational purposes and should not be considered investment, financial or trading advice.